Standard
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial) : Design and early dosimetric results of a randomized, multi-centre phase-III study. / Moller, Ditte Sloth; Nielsen, Tine Bjørn; Brink, Carsten; Hoffmann, Lone; Lutz, Christina Maria; Lund, Mikkel Drogemuller; Hansen, Olfred; Schytte, Tine; Khalil, Azza Ahmed; Knap, Marianne Marquard; Nyhus, Christa Haugaard; Ottosson, Wiviann; Sibolt, Patrik; Borissova, Svetlana; Josipovic, Mirjana; Persson, Gitte; Appelt, Ane Lindegaard.
I:
Radiotherapy & Oncology, Bind 124, Nr. 2, 08.2017, s. 311-317.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Moller, DS, Nielsen, TB, Brink, C, Hoffmann, L, Lutz, CM, Lund, MD, Hansen, O, Schytte, T, Khalil, AA, Knap, MM, Nyhus, CH, Ottosson, W, Sibolt, P, Borissova, S
, Josipovic, M, Persson, G & Appelt, AL 2017, '
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study',
Radiotherapy & Oncology, bind 124, nr. 2, s. 311-317.
https://doi.org/10.1016/j.radonc.2017.06.022APA
Moller, D. S., Nielsen, T. B., Brink, C., Hoffmann, L., Lutz, C. M., Lund, M. D., Hansen, O., Schytte, T., Khalil, A. A., Knap, M. M., Nyhus, C. H., Ottosson, W., Sibolt, P., Borissova, S.
, Josipovic, M., Persson, G., & Appelt, A. L. (2017).
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Radiotherapy & Oncology,
124(2), 311-317.
https://doi.org/10.1016/j.radonc.2017.06.022Vancouver
Moller DS, Nielsen TB, Brink C, Hoffmann L, Lutz CM, Lund MD o.a.
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study.
Radiotherapy & Oncology. 2017 aug.;124(2):311-317.
https://doi.org/10.1016/j.radonc.2017.06.022Author
Moller, Ditte Sloth ; Nielsen, Tine Bjørn ; Brink, Carsten ; Hoffmann, Lone ; Lutz, Christina Maria ; Lund, Mikkel Drogemuller ; Hansen, Olfred ; Schytte, Tine ; Khalil, Azza Ahmed ; Knap, Marianne Marquard ; Nyhus, Christa Haugaard ; Ottosson, Wiviann ; Sibolt, Patrik ; Borissova, Svetlana ; Josipovic, Mirjana ; Persson, Gitte ; Appelt, Ane Lindegaard. / Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial) : Design and early dosimetric results of a randomized, multi-centre phase-III study. I: Radiotherapy & Oncology. 2017 ; Bind 124, Nr. 2. s. 311-317.
Bibtex
@article{1044d9e6116c4a08a3188d62be69587c,
title = "Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study",
keywords = "NSCLC, Dose-escalation, Randomized phase-III trial",
author = "Moller, {Ditte Sloth} and Nielsen, {Tine Bj{\o}rn} and Carsten Brink and Lone Hoffmann and Lutz, {Christina Maria} and Lund, {Mikkel Drogemuller} and Olfred Hansen and Tine Schytte and Khalil, {Azza Ahmed} and Knap, {Marianne Marquard} and Nyhus, {Christa Haugaard} and Wiviann Ottosson and Patrik Sibolt and Svetlana Borissova and Mirjana Josipovic and Gitte Persson and Appelt, {Ane Lindegaard}",
year = "2017",
month = aug,
doi = "10.1016/j.radonc.2017.06.022",
language = "English",
volume = "124",
pages = "311--317",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",
}
RIS
TY - JOUR
T1 - Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial)
T2 - Design and early dosimetric results of a randomized, multi-centre phase-III study
AU - Moller, Ditte Sloth
AU - Nielsen, Tine Bjørn
AU - Brink, Carsten
AU - Hoffmann, Lone
AU - Lutz, Christina Maria
AU - Lund, Mikkel Drogemuller
AU - Hansen, Olfred
AU - Schytte, Tine
AU - Khalil, Azza Ahmed
AU - Knap, Marianne Marquard
AU - Nyhus, Christa Haugaard
AU - Ottosson, Wiviann
AU - Sibolt, Patrik
AU - Borissova, Svetlana
AU - Josipovic, Mirjana
AU - Persson, Gitte
AU - Appelt, Ane Lindegaard
PY - 2017/8
Y1 - 2017/8
KW - NSCLC
KW - Dose-escalation
KW - Randomized phase-III trial
U2 - 10.1016/j.radonc.2017.06.022
DO - 10.1016/j.radonc.2017.06.022
M3 - Journal article
C2 - 28688525
VL - 124
SP - 311
EP - 317
JO - Radiotherapy & Oncology
JF - Radiotherapy & Oncology
SN - 0167-8140
IS - 2
ER -
